Sam Altman’s Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
Sam Altman, co-founder of OpenAI and the visionary behind ChatGPT, recently opened up about his transformative experiences with psychedelics in his appearance on the podcast Life in Seven Songs. The tech executive shared personal anecdotes about how psychedelic experiences profoundly impacted his mental health, helping him overcome anxiety and find happiness.
Altman told to host Sophie Bearman that he once considered himself a “very anxious, unhappy person,” but psychedelic experiences—particularly a retreat in Mexico—changed his life significantly. “Doing psychedelics was one of the most transformative experiences of my life,” he said, noting that the experience helped him become a “calm person” and allowed him to focus more effectively on his work.
While Altman did not specify which psychedelics he used, he did mention that the Mexico retreat was particularly significant. “If you had told me that, like, one weekend-long retreat in Mexico was going to significantly change that, …